头颈癌游离皮瓣重建术后抗凝:系统综述
该研究系统检索 PubMed、Ovid 与 Cochrane 数据库,纳入 21 项报告头颈消融术后游离组织移植抗凝方案的研究进行定性分析。总体皮瓣失败率 4.4%、血栓形成率 4.5%、血肿形成率 2.2%,各研究间差异较大。结论认为现有证据不足以制定标准化抗凝方案,各抗凝方法间皮瓣并发症相当,但研究设计异质性显著,需前瞻性随机研究。
要点
- 总体皮瓣失败率 4.4%、血栓形成率 4.5%、血肿形成率 2.2%。
- 单项研究皮瓣失败率 0.0%–10.7%、血栓形成率 0.0%–10.4%、血肿率 0.6%–7.2%。
- 现有证据不足以制定头颈游离皮瓣术后标准化抗凝方案。
核心结论
- 现有证据不足以制定头颈游离皮瓣手术的标准化抗凝方案。
- 所研究的各抗凝方法之间报告的皮瓣并发症相当,但各研究设计存在显著异质性。
- 需要前瞻性随机研究来确定头颈游离组织移植术后最佳抗凝方案。
研究设计与样本
- 遵循 PRISMA 指南检索 PubMed、Ovid 和 Cochrane 数据库的英文研究。
- 共识别 368 篇文章,另经参考文献列表筛查补充 36 篇。
- 21 项研究符合最终纳入标准并进入定性分析。
- 两名独立评审者使用 MINORS(非随机研究方法学指数)评估文献质量。
主要发现
- 总体皮瓣失败率为 4.4%,单项研究范围为 0.0%–10.7%。
- 总体血栓形成率为 4.5%,单项研究范围为 0.0%–10.4%。
- 总体血肿形成率为 2.2%,单项研究范围为 0.6%–7.2%。
- 各抗凝方法之间报告的皮瓣并发症相当,但研究设计异质性显著。
关键数值与推荐
- 结局指标包括皮瓣完全失败、血栓形成和血肿形成。
- 系统综述遵循 PRISMA 指南,质量评估采用 MINORS 工具。
临床怎么用
- 原文未给出可直接用于临床的标准化抗凝方案,仅指出各抗凝方法间皮瓣并发症相当。
- 原文提出需前瞻性随机研究确定最佳术后抗凝方案。
局限性
- 原文述各纳入研究设计存在显著异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Postoperative use of anticoagulation after free tissue transfer in head and neck ablative procedures is common practice, but a clear protocol has not been well established. The outcome measures including total flap failure, thrombosis, and hematoma formation for different anticoagulation regimens in free tissue transfer in the head and neck were reviewed. DATA SOURCES: PubMed, Ovid, and Cochrane databases were examined for patients who underwent free tissue transfer following head and neck ablative procedures. REVIEW METHODS: Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines were utilized to identify English-language studies reporting anticoagulation regimens following free tissue transfer in head and neck ablative procedures. Outcomes included total flap failure, thrombosis, and hematoma formation. Two independent reviewers assessed the quality of the articles by using the Methodological Index for Non-Randomized Studies. RESULTS: A total of 368 articles were identified. An additional 36 articles were identified through screening of reference lists. Twenty-one of these studies met final inclusion criteria for qualitative analysis. Outcome data on total flap failure, thrombosis, and hematoma formation were extracted and analyzed for comparison against all anticoagulation regimens. Total flap failure, thrombosis, and hematoma formation rates were 4.4%, 4.5%, and 2.2%, respectively. Individual study rates ranged from 0.0% to 10.7%, 0.0% to 10.4%, and 0.6% to 7.2%, respectively. CONCLUSIONS: There is not adequate evidence to develop a standardized anticoagulation protocol for head and neck free flap procedures. Comparable flap complications were reported between all the employed anticoagulation methods studied, though significant variability in study design among articles existed. Prospective, randomized studies are warranted to determine the optimal postoperative anticoagulation regimen following free tissue transfer of the head and neck. Laryngoscope, 128:412-421, 2018.
引用
- Barton BM, Riley CA, Fitzpatrick JC, et al. Postoperative anticoagulation after free flap reconstruction for head and neck cancer: A systematic review. Laryngoscope. 2017. PMID: 28581030. doi:10.1002/lary.26703
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。